MedPath

Clinical Study On Virechana Effect Of Kalyanaka Guda Avaleha In Sthaulya

Phase 2
Completed
Conditions
Health Condition 1: E669- Obesity, unspecified
Registration Number
CTRI/2022/07/043704
Lead Sponsor
Diksha
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

1. Patients between age 18 to 60 years.

2. Patients diagnosed with obesity.

3. Patients having BMI 30 or above in males, BMI 28.6 or above in females.

4. Waist to Hip ratio 0.95 or above in male, 0.8 or above in female.

5. Patients fit for Virechana.

Exclusion Criteria

1 Patient above 60 years, below 18 years will be excluded.

2. Pregnant women, lactating mothers will be excluded.

3. Patients having metabolic disturbances, hypertension, diabetes mellitus, other chronic acute diseases, IHD, Alcoholic patients, Hypothyroidism, Cushing Syndrome.

4.Patient Contraindicated for Virechana

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Kalyanaka Guda Avaleha will have Virechana effects. <br/ ><br>Kalyanaka Guda Avaleha will be effective in reducing symptoms of SthaulyaTimepoint: 30 days study with two follow up on 8th day and 30th day of Virechana Vidhi
Secondary Outcome Measures
NameTimeMethod
Kalyanak Guda Avaleha may also show reduction in Cholestrol levelsTimepoint: 30 days study with two follow up on 8th day and 30th day of Virechana Vidhi
© Copyright 2025. All Rights Reserved by MedPath